[1]
“Systemic Light-Chain Amyloidosis: Evolving Diagnostic Paradigms and Emerging Therapeutic Strategies Beyond ANDROMEDA ”, Curr. Trends Med. Clin. Res., vol. 5, no. 4, Oct. 2026, doi: 10.5281/zenodo.23790867.